287 related articles for article (PubMed ID: 29704548)
21. CDK5 protects from caspase-induced Ataxin-3 cleavage and neurodegeneration.
Liman J; Deeg S; Voigt A; Voßfeldt H; Dohm CP; Karch A; Weishaupt J; Schulz JB; Bähr M; Kermer P
J Neurochem; 2014 Jun; 129(6):1013-23. PubMed ID: 24548080
[TBL] [Abstract][Full Text] [Related]
22. Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.
Raj K; Akundi RS
Mol Neurobiol; 2021 Jul; 58(7):3095-3118. PubMed ID: 33629274
[TBL] [Abstract][Full Text] [Related]
23. Polyglutamine expansion of ataxin-3 alters its degree of ubiquitination and phosphorylation at specific sites.
Kristensen LV; Oppermann FS; Rauen MJ; Hartmann-Petersen R; Thirstrup K
Neurochem Int; 2017 May; 105():42-50. PubMed ID: 28065793
[TBL] [Abstract][Full Text] [Related]
24. Caffeic acid and resveratrol ameliorate cellular damage in cell and Drosophila models of spinocerebellar ataxia type 3 through upregulation of Nrf2 pathway.
Wu YL; Chang JC; Lin WY; Li CC; Hsieh M; Chen HW; Wang TS; Wu WT; Liu CS; Liu KL
Free Radic Biol Med; 2018 Feb; 115():309-317. PubMed ID: 29247688
[TBL] [Abstract][Full Text] [Related]
25. The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits.
Koppenol R; Conceição A; Afonso IT; Afonso-Reis R; Costa RG; Tomé S; Teixeira D; da Silva JP; Côdesso JM; Brito DVC; Mendonça L; Marcelo A; Pereira de Almeida L; Matos CA; Nóbrega C
Brain; 2023 Jun; 146(6):2346-2363. PubMed ID: 36511898
[TBL] [Abstract][Full Text] [Related]
26. Karyopherin α-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3.
Sowa AS; Martin E; Martins IM; Schmidt J; Depping R; Weber JJ; Rother F; Hartmann E; Bader M; Riess O; Tricoire H; Schmidt T
Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2624-E2633. PubMed ID: 29476013
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of transglutaminase exacerbates polyglutamine-induced neurotoxicity by increasing the aggregation of mutant ataxin-3 in an SCA3 Drosophila model.
Lin Y; He H; Luo Y; Zhu T; Duan R
Neurotox Res; 2015 Apr; 27(3):259-67. PubMed ID: 25501875
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in
Prifti MV; Libohova K; Harris AL; Tsou WL; Todi SV
Front Neurosci; 2022; 16():1112688. PubMed ID: 36733922
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23.
Blount JR; Tsou WL; Ristic G; Burr AA; Ouyang M; Galante H; Scaglione KM; Todi SV
Nat Commun; 2014 Aug; 5():4638. PubMed ID: 25144244
[TBL] [Abstract][Full Text] [Related]
30. Lysine 117 on ataxin-3 modulates toxicity in
Blount JR; Patel NC; Libohova K; Harris AL; Tsou WL; Sujkowski A; Todi SV
bioRxiv; 2023 Jun; ():. PubMed ID: 37398109
[TBL] [Abstract][Full Text] [Related]
31. Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3.
Wang ZJ; Hanet A; Weishäupl D; Martins IM; Sowa AS; Riess O; Schmidt T
CNS Neurosci Ther; 2018 May; 24(5):404-411. PubMed ID: 29318784
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometry allows rapid detection of protein aggregates in cellular and zebrafish models of spinocerebellar ataxia 3.
Robinson KJ; Tym MC; Hogan A; Watchon M; Yuan KC; Plenderleith SK; Don EK; Laird AS
Dis Model Mech; 2021 Oct; 14(10):. PubMed ID: 34473252
[TBL] [Abstract][Full Text] [Related]
33. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
[TBL] [Abstract][Full Text] [Related]
34. Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3.
Jung J; Xu K; Lessing D; Bonini NM
Hum Mol Genet; 2009 Dec; 18(24):4843-52. PubMed ID: 19783548
[TBL] [Abstract][Full Text] [Related]
35. Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.
Ramani B; Panwar B; Moore LR; Wang B; Huang R; Guan Y; Paulson HL
Hum Mol Genet; 2017 Sep; 26(17):3362-3374. PubMed ID: 28854700
[TBL] [Abstract][Full Text] [Related]
36. Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity.
Ghosh B; Karmakar S; Prasad M; Mandal AK
Mol Biol Cell; 2021 Aug; 32(17):1579-1593. PubMed ID: 34161122
[TBL] [Abstract][Full Text] [Related]
37. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.
Perez MK; Paulson HL; Pendse SJ; Saionz SJ; Bonini NM; Pittman RN
J Cell Biol; 1998 Dec; 143(6):1457-70. PubMed ID: 9852144
[TBL] [Abstract][Full Text] [Related]
38. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.
Warrick JM; Morabito LM; Bilen J; Gordesky-Gold B; Faust LZ; Paulson HL; Bonini NM
Mol Cell; 2005 Apr; 18(1):37-48. PubMed ID: 15808507
[TBL] [Abstract][Full Text] [Related]
39. Coiled-coil structure-dependent interactions between polyQ proteins and Foxo lead to dendrite pathology and behavioral defects.
Kwon MJ; Han MH; Bagley JA; Hyeon DY; Ko BS; Lee YM; Cha IJ; Kim SY; Kim DY; Kim HM; Hwang D; Lee SB; Jan YN
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10748-E10757. PubMed ID: 30348793
[TBL] [Abstract][Full Text] [Related]
40. The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases.
Potapenko A; Davidson JM; Lee A; Laird AS
Biochem J; 2024 Mar; 481(6):461-480. PubMed ID: 38497605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
